Screener
Sarepta Therapeutics, Inc. SRPT Business Segments — Gain Loss On Investments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:GainLossOnInvestments.
The source filing: Sarepta Therapeutics, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:01 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-335003
| Line item | For the Three Months Ended June 30, 2026 | For the Three Months Ended June 30, 2025 | For the Six Months Ended June 30, 2026 | For the Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Selling, general and administrative- other (excluding non-cash items) (2) | 42,462 | 56,322 | 82,655 | 107,464 |
| Roche collaboration reimbursement | (7,169) | (25,689) | (15,358) | (54,170) |
| Other segment items (3) | (709) | (1,314) | (2,515) | (3,223) |
| Loss (gain) on strategic investments | 448 | (36,721) | 2,160 | 54,007 |
| Interest expense | 21,508 | 5,228 | 43,221 | 9,731 |
| Interest income | (6,207) | (5,254) | (12,567) | (15,444) |
| Income tax expense (benefit) | 3,141 | (43,254) | 15,356 | 20,736 |
| Depreciation and amortization expense | 10,409 | 10,840 | 21,003 | 20,818 |
Item 1. Financial Statements
FAQ
- What is Sarepta Therapeutics, Inc.'s business segments — gain loss on investments?
- Sarepta Therapeutics, Inc. (SRPT) reported business segments — gain loss on investments of $448K in Q2 2026.
- How has Sarepta Therapeutics, Inc.'s business segments — gain loss on investments changed year-over-year?
- Sarepta Therapeutics, Inc.'s business segments — gain loss on investments increased by 101.2% year-over-year, from -$36.72M to $448K.
- What is the long-term trend for Sarepta Therapeutics, Inc.'s business segments — gain loss on investments?
- Over 2 years (2023 to 2025), Sarepta Therapeutics, Inc.'s business segments — gain loss on investments has grown at a 222.8% compound annual growth rate (CAGR), from $1.53M to -$15.91M.
- What does business segments — gain loss on investments mean?
- Represents the net realized and unrealized gains or losses recognized on the segment's investment portfolio. This metric reflects the performance of non-operating financial assets and market-driven valuation changes. It provides insight into the segment's secondary financial returns beyond core business operations.
Ask your AI about Sarepta Therapeutics, Inc.'s business segments — gain loss on investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude